Aravax’s peanut allergy drug shows benefit in paediatric patients
Aravax’s Phase II peanut allergy trial met its primary endpoint, with younger paediatric patients able to better tolerate peanuts after…
Aravax’s Phase II peanut allergy trial met its primary endpoint, with younger paediatric patients able to better tolerate peanuts after…